MIR1183: A Potential Drug Target and Biomarker (G100302122)
MIR1183: A Potential Drug Target and Biomarker
Molecular Imaging Research (MIR) has revolutionized the study of cancer biology, providing researchers with a deeper understanding of disease mechanisms and the potential for new treatments. One promising target for MIR is MIR1183, a protein that has been identified as a potential drug target in various types of cancer. In this article, we will explore the biology of MIR1183, its potential as a drug target, and its potential as a biomarker for cancer diagnosis and treatment.
The MIR1183 Protein
MIR1183 is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the Mir gene family, which is known for its role in the development and maintenance of tissues, including blood vessels, neural lines, and cancer cells. MIR1183 has been shown to play a role in cell signaling, specifically in the regulation of cell adhesion and migration.
In addition to its role in cell signaling, MIR1183 has also been shown to play a role in the regulation of inflammation and immune responses. MIR1183 has been shown to interact with various signaling pathways, including the TGF-β pathway, which is involved in cell signaling and tissue growth, as well as the NF-kappa-B pathway, which is involved in inflammation and immune responses.
MIR1183 as a Drug Target
MIR1183's potential as a drug target is based on its unique structure and its involvement in various signaling pathways. One of the main advantages of MIR1183 as a drug target is its stability. MIR1183 has been shown to have a long half-life of several hours, which allows for efficient dosing and long-term treatment. Additionally, MIR1183 is a protein that is expressed in various tissues of the body, which makes it a potential target for drugs that can cross-react with it in different tissues.
In addition to its stability and its potential as a protein, MIR1183's role in cell signaling also makes it an attractive drug target. MIR1183 has been shown to play a role in the regulation of cell adhesion and migration, which are important processes that are involved in the development of cancer. Additionally, MIR1183's involvement in cell signaling has also led to its potential as a target for drugs that can modulate cell signaling pathways, such as tyrosine kinase inhibitors.
MIR1183 as a Biomarker
MIR1183's potential as a drug target also makes it an attractive biomarker for cancer diagnosis and treatment. Cancer is a disease that is characterized by the uncontrolled growth and proliferation of cells, which can lead to a wide range of symptoms and a decreased quality of life. As such, the development of new biomarkers for cancer diagnosis and treatment is a major area of research in the field of cancer biology.
MIR1183 has been shown to have potential as a biomarker for cancer diagnosis and treatment by its expression in various tissues of the body, as well as its involvement in cell signaling. MIR1183 has been shown to be expressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, MIR1183 has been shown to have potential as a diagnostic biomarker by its expression in various types of cancer, including breast and ovarian cancer.
MIR1183 has also been shown to have potential as a therapeutic biomarker. For example, MIR1183 has been shown to be an
Protein Name: MicroRNA 1183
The "MIR1183 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1183 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287
